JPS5965014A - ２５−ヒドロキシビタミンｄ↓３−２６，２３−パ−オキシラクトンを活性成分とするカルシユウム調節剤 - Google Patents

２５−ヒドロキシビタミンｄ↓３−２６，２３−パ−オキシラクトンを活性成分とするカルシユウム調節剤

Info

Publication number
JPS5965014A
JPS5965014A JP17526582A JP17526582A JPS5965014A JP S5965014 A JPS5965014 A JP S5965014A JP 17526582 A JP17526582 A JP 17526582A JP 17526582 A JP17526582 A JP 17526582A JP S5965014 A JPS5965014 A JP S5965014A
Authority
JP
Japan
Prior art keywords
hydroxyvitamin
peroxylactone
calcium
vitamin
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP17526582A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0136805B2 (en]
Inventor
Seiichi Ishizuka
誠一 石塚
Yoritsugu Kubo
久保　順嗣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP17526582A priority Critical patent/JPS5965014A/ja
Priority to DE19823247836 priority patent/DE3247836A1/de
Priority to FR8222038A priority patent/FR2518881B1/fr
Priority to US06/454,309 priority patent/US4511564A/en
Priority to CH7617/82A priority patent/CH652929A5/de
Publication of JPS5965014A publication Critical patent/JPS5965014A/ja
Publication of JPH0136805B2 publication Critical patent/JPH0136805B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP17526582A 1981-12-29 1982-10-07 ２５−ヒドロキシビタミンｄ↓３−２６，２３−パ−オキシラクトンを活性成分とするカルシユウム調節剤 Granted JPS5965014A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP17526582A JPS5965014A (ja) 1982-10-07 1982-10-07 ２５−ヒドロキシビタミンｄ↓３−２６，２３−パ−オキシラクトンを活性成分とするカルシユウム調節剤
DE19823247836 DE3247836A1 (de) 1981-12-29 1982-12-23 Arzneimittel und verwendung derselben zur steuerung der serumcalciumkonzentration bei warmbluetern
FR8222038A FR2518881B1 (fr) 1981-12-29 1982-12-29 Medicaments a base de 26,23-lactones de la 25-hydroxyvitamine d3, utiles notamment pour agir sur la concentration en calcium du serum
US06/454,309 US4511564A (en) 1981-12-29 1982-12-29 Methods of controlling the concentration of calcium in the serum of warm-blooded animals and pharmaceutical compositions to be used therefor
CH7617/82A CH652929A5 (de) 1981-12-29 1982-12-29 Pharmazeutisches praeparat zur regulierung der konzentration an calcium im serum von menschen und warmbluetigen tieren und peroxylactone.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17526582A JPS5965014A (ja) 1982-10-07 1982-10-07 ２５−ヒドロキシビタミンｄ↓３−２６，２３−パ−オキシラクトンを活性成分とするカルシユウム調節剤

Publications (2)

Publication Number Publication Date
JPS5965014A true JPS5965014A (ja) 1984-04-13
JPH0136805B2 JPH0136805B2 (en]) 1989-08-02

Family

ID=15993125

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17526582A Granted JPS5965014A (ja) 1981-12-29 1982-10-07 ２５−ヒドロキシビタミンｄ↓３−２６，２３−パ−オキシラクトンを活性成分とするカルシユウム調節剤

Country Status (1)

Country Link
JP (1) JPS5965014A (en])

Also Published As

Publication number Publication date
JPH0136805B2 (en]) 1989-08-02

Similar Documents

Publication Publication Date Title
JP4493340B2 (ja) １α−ヒドロキシ−２−メチレン−１９−ノル−プレグナカルシフェロール及びその使用
DE3024855C2 (en])
FR2645441A1 (fr) Traitement de l'hyperparathyroidie par l'utilisation de derives de la vitamine d
DE69834109T2 (de) 3-epi-vitamin d2 verbindungen und ihre anwendungen
JPH02288829A (ja) 骨の損耗の予防又は再生不調症の治療又は予防用薬剤
FR2477145A1 (fr) 25-hydroxy-26, 26, 26, 27, 27, 27-hexafluorocholecalciferol
US4617297A (en) Method of treating disease states by the administration of 1α,25,26-trihydroxycholecalciferol
SE453636B (sv) 1,2,3,4-tetrahydro-1,1,4,4-tetrametyl-6-(alfa-metylstyryl)naftalen till anvendning som farmaceutisk substans for minskning av talgsekretionen
Baksi et al. Does estradiol stimulate in vivo production of 1, 25-dihydroxyvitamin D3 in the rat?
JP3255926B2 (ja) 腎機能障害患者における燐酸塩過剰血症予防のための１９−ノル−ビタミンｄ化合物の使用
JPS5965014A (ja) ２５−ヒドロキシビタミンｄ↓３−２６，２３−パ−オキシラクトンを活性成分とするカルシユウム調節剤
JPS60120812A (ja) 糖尿病性骨減少症治療剤
Kumar et al. Physiology of 24, 25-dihydroxyvitamin D3 in normal human subjects
JPH0780773B2 (ja) 新規ビタミンｄ▲下３▼誘導体を有効成分とする医薬
DE69634494T2 (de) Verwendung von Vitamin-D-Derivaten zur Herstellung eines Medikaments zur Behandlung von malignen Tumormetastasen
JPH0319207B2 (en])
US3870792A (en) Certain dihydrophthalizines for treating hemorrhage and thrombosis
FR2545824A1 (fr) Derive 1a, 25-dihydroxyles de la vitamine d2 et produits intermediaires pour leur preparation et compositions pharmaceutiques renfermant ces derives
JPS6341370B2 (en])
Younoszai et al. Influence of vitamin D on in vivo intestinal calcium transport in normal rats
IE54722B1 (en) Use of cholecalciferol derivatives
JPS6342606B2 (en])
JPS6141351B2 (en])
US5571802A (en) Method of treating post menopausal osteoporosis with hexafluro-vitamin D
JPS59175425A (ja) 脳卒中予防剤